ATH434

The shares of Alterity Therapeutics Ltd. (NASDAQ: ATHE) advanced in the after-hours session trading in New York on Monday and in the regular session in Sydney on Tuesday. What Happened: The surge came as Alterity Therapeutics reported positive data from an animal testing of ATH434 — its leading...